Episode 13: Volume, Glow, and ...Granulomas? The Real Deal on Sculptra
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 13: Volume, Glow, and ...Granulomas? The Real Deal on Sculptra
-
ナレーター：
-
著者：
このコンテンツについて
You’ve heard the buzz — Sculptra promises natural volume, glowing skin, and long-lasting results. But is this biostimulatory injectable really the collagen dream it claims to be… or a delayed disaster waiting to happen?
In this episode of Behind the Dirty Needle, we break down everything you need to know about Sculptra: how it works, why people love it, and the not-so-glamorous risks that don’t make it into the marketing. From granulomas and migration to complications with future facelifts, we’re spilling the clinical tea and helping you figure out if this treatment is a smart investment — or a collagen landmine.
We’ll share:
- What makes Sculptra different from filler or Botox
- Who it’s great for (and who should run far, far away)
- The red flags to look for when choosing a provider
- Real stories of Sculptra wins… and horror shows
Whether you’re a patient considering it or a provider offering it, this is the real deal on the injectable that’s definitely not just another filler.